Last Updated

Memorial Sloan Kettering Cancer Center (MSK) has successfully reached a new agreement with Anthem Blue Cross Blue Shield, effective January 2, 2025

MSK has an obligation to ensure reimbursement rates allow us to continue delivering the best outcomes and the most cost-effective cancer care in the region for patients and we will never waiver in that advocacy. This agreement ensures MSK remains in-network for Anthem members, allowing approximately 22,000 active patients, as well as millions of people across the tri-state area and beyond, to continue having access to the best outcomes in the nation for cancer care.

At MSK, our mission is to end cancer for life. We pursue that mission every day through cutting-edge research, compassionate care, and a relentless commitment to delivering the best patient outcomes in the nation.

Sincerely,
Selwyn M. Vickers, MD, FACS
President and Chief Executive Officer
Memorial Sloan Kettering Cancer Center